drugset / Trial / NCT04111432
Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines
Phase 4
Completed
372 enrolled
Sinovac Biotech Co., Ltd
Shaanxi Provincial Center for Disease Control and Prevention · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of concomitant administration of EV71 vaccine with measles mumps, and rubella combined live attenuated vaccine/ encephalitis live attenuated vaccine.
Timeline
- Start
- 2019-07-26
- Primary completion
- 2019-11-25
- Completion
- 2020-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EV71 vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | Live attenuated Japanese encephalitis vaccine | Vaccine | 0.5 ml | Subcutaneous |
| Subject | MMR vaccine | Vaccine | 0.5 ml | Subcutaneous |